Firm targets America with cancer treatment product

CRICKETERS have got it covered thanks to a £1,000 donation.

The Almondbury Wesleyans Cricket Club desperately needed new covers to protect the cricket field.

And they were helped by the Colne Valley Masonic Lodge’s charitable fund.

Robert Shaw, charity steward of the Colne Valley Lodge, said: “This cricket club has a good youth section and they needed some money to keep the cricket field covered and protected.

“The money came from the Provincial Grandmasters Fund, which we can use to help worthy community clubs when they apply for financial assistance.

“There are a few keen cricketers in the Lodge and we were happy to help them.”

Almondbury Wesleyans play in the Huddersfield Drakes league 1st & 2nd XI and Halifax Sunday league 3rd XI. review period for applications but typically approval can take 150 days. Paxman hopes to get the green lights in the first half of 2017.

Paxman coolers are already wellestablished in the UK and parts of Europe and Asia, but FDA approval would see Paxman break into the world’s biggest health market.

The first cooler was devised 20 years ago when Richard’s late mother, Sue, was undergoing chemotherapy. Seeing her distress at losing her hair and drawing on their expertise in beer cooling technology, Sue’s husband Glenn and his brother Neil developed the cooler, which works by restricting the flow of blood – and the Robert Shaw (right) of Colne Valley Masonic Lodge, presents a £1,000 cheque to Almondbury Wesleyans CC chairman Stephen Fisher and players Alex Taylor and Oliver Ghee chemicals used in the treatment – to the scalp and hair follicles.

The latest version – used in more than 2,000 hospitals, clinics and treatment centres around the world – involves a form-fitting silicon cap in which a coolant is circulated to reduce the temperature of the scalp. The cap is worn before, during and after chemotherapy sessions.

Richard said: “It is such an honour that our clinical trial findings used in the FDA submission were chosen to be presented at SABCS. This is a real privilege for not only the researchers involved but for all the patients that took part in the trials.”

The US clinical trials were led by Julie Nangia, assistant professor of medicine at Baylor College of Medicine, Houston, which houses the Lester and Sue Smith Breast Center.

Other clinical trials involving 186 women were held at several other sites, including cancer centres in Cleveland, Ohio; Morristown, New Jersey; and oncology sites in Dallas and Houston, Texas.